Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma.
暂无分享,去创建一个
[1] Min Lu,et al. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. , 2004, World journal of gastroenterology.
[2] H. Ozkan,et al. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. , 2003, Hepato-gastroenterology.
[3] A. Bergquist,et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.
[4] W. Silverman,et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2002, Gastrointestinal endoscopy.
[5] M. Makuuchi,et al. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. , 2002, Hepato-gastroenterology.
[6] Y. Yasukochi,et al. Differentiation‐Induced Transmigration of HL60 Cells across Activated HUVEC Monolayer Involves E‐selectin‐Dependent Mechanism a , 2000, Annals of the New York Academy of Sciences.
[7] M. Aubert,et al. Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. , 2000, Cancer research.
[8] N. Chalasani,et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case‐control study , 2000, Hepatology.
[9] G. Gores,et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.
[10] J. L. Goodman,et al. A cloned CD15s‐negative variant of HL60 cells is deficient in expression of FUT7 and does not adhere to cytokine‐stimulated endothelial cells , 1999, European journal of haematology.
[11] Å. Danielsson,et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. , 1999, Journal of hepatology.
[12] H. Mori,et al. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with α‐fetoprotein, carcinoembryonic antigen, CA19‐9, epithelial membrane antigen, and cytokeratins 18 and 19 , 1999, Pathology international.
[13] K. Lillemoe,et al. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis , 1998, Journal of Gastrointestinal Surgery.
[14] D L Morton,et al. Endothelial‐selectin ligands sialyl Lewisx and sialyl Lewisa are differentiation antigens immunogenic in human melanoma , 1997, Cancer.
[15] W. Yoon,et al. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. , 1996, Biochemical and biophysical research communications.
[16] T. Terada,et al. Expression of blood group‐related antigens in cholangiocarcinoma in relation to non‐neoplastic bile ducts , 1996, Histopathology.
[17] R. Kannagi,et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. , 1993, Cancer research.
[18] I. Fidler,et al. Regulation of tumor cell growth at organ-specific metastases. , 1992, In vivo.
[19] M. Kiso,et al. Structural requirements for the carbohydrate ligand of E-selectin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Kannagi,et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. , 1991, Biochemical and biophysical research communications.
[21] F. Gaeta,et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. , 1990, Science.
[22] J. Lowe,et al. ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA , 1990, Cell.
[23] V. Titapant,et al. A high incidence of liver cancer in Khon Kaen Province, Thailand. , 1990, The Southeast Asian journal of tropical medicine and public health.
[24] S. Hakomori,et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. , 1988, Cancer research.
[25] R. Kannagi,et al. Fucosylated type‐2 chain polylactosamine antigens in human lung cancer , 1988, International journal of cancer.
[26] H. Koprowski,et al. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.
[27] V. Zurawski,et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. , 1983, Clinical chemistry.
[28] M. Herlyn,et al. Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.